| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26415-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26414-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47743-0.1mg | |||
| IHC-Prediluted | NBP2-48218 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-47897-0.1mg | |||
| IHC-Prediluted | NBP2-48384 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-54330-100ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26247-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21623-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-21552-50ul | |||
![Immunoprecipitation: Jak2 [p Tyr1007, p Tyr1008] Antibody (1A4) [NBP3-26415] - Immunoprecipitating Jak2 [p Tyr1007, p Tyr1008] in Hela whole cell lysate treated with Pervanadate. Lane 1: Rabbit control IgG (1ug) instead of NBP3-26415 in Hela whole cell lysate treated with Pervanadate. For western blotting, a HRP-conjugated Protein G antibody was used as the secondary antibody (1/2000). Lane 2: NBP3-26415 (3ug) + Hela whole cell lysate treated with Pervanadate (1mg). Lane 3: Hela whole cell lysate treated with Pervanadate (20ug).](http://images.novusbio.com/fullsize/nbp3-26415_rabbit-jak2-p-tyr-1007-p-tyr-1008-mab-1a4-262202413221522.jpg "Immunoprecipitation: Jak2 [p Tyr1007, p Tyr1008] Antibody (1A4) [NBP3-26415] - Immunoprecipitating Jak2 [p Tyr1007, p Tyr1008] in Hela whole cell lysate treated with Pervanadate. Lane 1: Rabbit control IgG (1ug) instead of NBP3-26415 in Hela whole cell lysate treated with Pervanadate. For western blotting, a HRP-conjugated Protein G antibody was used as the secondary antibody (1/2000). Lane 2: NBP3-26415 (3ug) + Hela whole cell lysate treated with Pervanadate (1mg). Lane 3: Hela whole cell lysate treated with Pervanadate (20ug).")
![Immunohistochemistry: Jak2 [p Tyr1007, p Tyr1008] Antibody (1A4) [NBP3-26415] - Image of Jak2 [p Tyr1007, p Tyr1008] Antibody (1A4) diluted at 1:100 and staining in paraffin-embedded human ovarian cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/nbp3-26415_rabbit-jak2-p-tyr-1007-p-tyr-1008-mab-1a4-262202414471549.jpg)
![Immunohistochemistry: Jak2 [p Tyr1007, p Tyr1008] Antibody (1A4) [NBP3-26415] - Image of Jak2 [p Tyr1007, p Tyr1008] Antibody (1A4) diluted at 1:100 and staining in paraffin-embedded human ovarian cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/nbp3-26415_rabbit-jak2-p-tyr-1007-p-tyr-1008-mab-1a4-27220248274910.jpg)
![Western Blot: Jak2 [p Tyr1007, p Tyr1008] Antibody (1A4) [NBP3-26415] - Positive Western Blot detected in Hela whole cell lysate, A549 whole cell lysate (treated with Pervanadate or not). All lanes: Jak2 [p Tyr1007, p Tyr1008] Antibody at 0.75ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 120 KDa Observed band size: 120 KDa](http://images.novusbio.com/fullsize/nbp3-26415_rabbit-jak2-p-tyr-1007-p-tyr-1008-mab-1a4-282202411413613.jpg)
![Western Blot: Jak2 Antibody [NBP1-22975] - Whole cell lysate from Jurkat (5, 15 and 50 ug for WB; 1 mg for IP, 20% of IPloaded) and HeLa (H; 50 ug) cells. Antibodies: Affinity purified rabbit anti-JAK2 antibody used for WB at 0.1 ug/ml (A) and 1 ug/ml (B) and used for IP at 10 ug/mg lysate. JAK2 was also immunoprecipitated by rabbit anti-JAK2 antibody BL3496, which recognizes an upstream epitope. Detection: Chemiluminescence with exposure times of 30 seconds (A) and 10 seconds (B).](http://images.novusbio.com/fullsize/Jak2-Antibody-Western-Blot-NBP1-22975-img0004.jpg "Western Blot: Jak2 Antibody [NBP1-22975] - Whole cell lysate from Jurkat (5, 15 and 50 ug for WB; 1 mg for IP, 20% of IPloaded) and HeLa (H; 50 ug) cells. Antibodies: Affinity purified rabbit anti-JAK2 antibody used for WB at 0.1 ug/ml (A) and 1 ug/ml (B) and used for IP at 10 ug/mg lysate. JAK2 was also immunoprecipitated by rabbit anti-JAK2 antibody BL3496, which recognizes an upstream epitope. Detection: Chemiluminescence with exposure times of 30 seconds (A) and 10 seconds (B).")
![Immunohistochemistry-Paraffin: Jak2 Antibody [NBP1-22975] - Human prostate carcinoma. Antibody: Affinity purified rabbit anti-JAK2 used at a dilution of 1:1,000 (1ug/ml). Detection: DAB.](http://images.novusbio.com/fullsize/Jak2-Antibody-Immunohistochemistry-Paraffin-NBP1-22975-img0003.jpg)
![Immunohistochemistry: c-jun [p Ser63] Antibody (4A11) [NBP3-26414] - Image of c-jun [p Ser63] Antibody (4A11) diluted at 1:100 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/nbp3-26414_rabbit-c-jun-p-ser-63-mab-4a11-2722024850463.jpg "Immunohistochemistry: c-jun [p Ser63] Antibody (4A11) [NBP3-26414] - Image of c-jun [p Ser63] Antibody (4A11) diluted at 1:100 and staining in paraffin-embedded human breast cancer performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4°C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.")
![Western Blot: c-jun [p Ser63] Antibody (4A11) [NBP3-26414] - Positive Western Blot detected in: Hela whole cell lysate, A549 whole cell lysate (treated with Calyculin A or EGF). All lanes: c-jun [p Ser63] Antibody at 0.95 ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 48 KDa Observed band size: 48 KDa](http://images.novusbio.com/fullsize/nbp3-26414_rabbit-c-jun-p-ser-63-mab-4a11-282202411472127.jpg)
![Immunocytochemistry/Immunofluorescence: c-jun [p Ser63] Antibody (4A11) [NBP3-26414] - Staining of A549 cells with c-jun [p Ser63] Antibody (4A11) at 1:100, counter-stained with DAPI. The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 488-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26414_rabbit-c-jun-p-ser-63-mab-4a11-28220241312248.jpg)
![Immunohistochemistry-Paraffin: EGFR Antibody (31G7 + GFR1195) [NBP2-45151] - Human Placenta stained with EGFR Monoclonal Antibody (31G7 + GFR1195).](http://images.novusbio.com/fullsize/EGFR-Antibody-31G7-+-GFR1195-Immunohistochemistry-Paraffin-NBP2-45151-img0001.jpg "Immunohistochemistry-Paraffin: EGFR Antibody (31G7 + GFR1195) [NBP2-45151] - Human Placenta stained with EGFR Monoclonal Antibody (31G7 + GFR1195).")
![Western Blot: p21/CIP1/CDKN1A Antibody (CIP1/823 + DCS-60.2) [NBP2-44529] - Analysis of human HeLa cell lysate using p21/CIP1/CDKN1A Antibody (CIP1/823 + DCS-60.2).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-823-+-DCS-60-2-Western-Blot-NBP2-44529-img0003.jpg "Western Blot: p21/CIP1/CDKN1A Antibody (CIP1/823 + DCS-60.2) [NBP2-44529] - Analysis of human HeLa cell lysate using p21/CIP1/CDKN1A Antibody (CIP1/823 + DCS-60.2).")
![Immunohistochemistry-Paraffin: p21/CIP1/CDKN1A Antibody (CIP1/823 + DCS-60.2) [NBP2-44529] - Human Bladder Carcinoma stained with p21 Monoclonal Antibody (CIP1/823 + DCS-60.2).](http://images.novusbio.com/fullsize/p21-CIP1-CDKN1A-Antibody-CIP1-823-+-DCS-60-2-Immunohistochemistry-Paraffin-NBP2-44529-img0001.jpg)
![Western Blot: E2F-1 [p Ser364] Antibody [NB600-900] - Panel A: Control antibody reactive to all forms of E2F (arrowheads). Panel B: Reactivity with phosphorylated E2F-1 (arrows) using E2F-1 [p Ser364] antibody. Lysate cells: CRE/E2F-1 CRE (human E2F-1 transfected mouse NIH3T3); NIH-3T3 (-ve control), & MDA-MB-231. Each lysate prepared from untreated cells & cells with 2 uM Doxorubicin. MDA-MB-231 also treated with genistein. Same membrane probed with E2F-1 [p Ser364] antibody @ 1:250 dilution, then stripped & re-probed with pan E2F antibody (+ve control). +ve control antibody shows an E2F-1 band in all human cell lines, but not mouse cells. Doxorubicin increases expression of E2F-1 (Panel A). Images overlapped to confirm that specific anti-E2F-1 pS364 staining shown in treated human cells in Panel B specifically aligns with E2F-1 staining shown in Panel A. Blots can be processed with HRP conjugated Gt-a-Rabbit IgG MX10 for 45 min at RT for ECL detection.](http://images.novusbio.com/fullsize/E2F-1-[p-Ser364]-Antibody-Western-Blot-NB600-900-img0007.jpg "Western Blot: E2F-1 [p Ser364] Antibody [NB600-900] - Panel A: Control antibody reactive to all forms of E2F (arrowheads). Panel B: Reactivity with phosphorylated E2F-1 (arrows) using E2F-1 [p Ser364] antibody. Lysate cells: CRE/E2F-1 CRE (human E2F-1 transfected mouse NIH3T3); NIH-3T3 (-ve control), & MDA-MB-231. Each lysate prepared from untreated cells & cells with 2 uM Doxorubicin. MDA-MB-231 also treated with genistein. Same membrane probed with E2F-1 [p Ser364] antibody @ 1:250 dilution, then stripped & re-probed with pan E2F antibody (+ve control). +ve control antibody shows an E2F-1 band in all human cell lines, but not mouse cells. Doxorubicin increases expression of E2F-1 (Panel A). Images overlapped to confirm that specific anti-E2F-1 pS364 staining shown in treated human cells in Panel B specifically aligns with E2F-1 staining shown in Panel A. Blots can be processed with HRP conjugated Gt-a-Rabbit IgG MX10 for 45 min at RT for ECL detection.")
![Immunohistochemistry: E2F-1 [p Ser364] Antibody [NB600-900] - Affinity Purified E2F-1 [p Ser364] antibody was used at a 10 ug/ml to detect nuclear and occasionally cytoplasmic signal in a variety of tissues including multi-human, multi-brain and multi-cancer slides. Within the multi-tumor block, the antibody showed variable levels of nuclear staining between individual tumors, with some tumors showing strong staining. This image shows E2F-1 pS364 staining of human breast carcinoma. Tissue was formalin-fixed and paraffin embedded.](http://images.novusbio.com/fullsize/E2F-1-[p-Ser364]-Antibody-Immunohistochemistry-NB600-900-img0008.jpg)
![Western Blot: E2F-1 [p Ser364] Antibody [NB600-900] - NB600-900 Western blot - E2F1 (phospho S364) antibody](http://images.novusbio.com/fullsize/E2F-1-[p-Ser364]-Antibody-Western-Blot-NB600-900-img0001.jpg)
![Western Blot: EGFR Antibody (GFR/1708) [NBP2-53198] - Western Blot Analysis of A431 cell lysate using EGFR antibody (GFR/1708).](http://images.novusbio.com/fullsize/EGFR-Antibody-GFR-1708-Western-Blot-NBP2-53198-img0004.jpg "Western Blot: EGFR Antibody (GFR/1708) [NBP2-53198] - Western Blot Analysis of A431 cell lysate using EGFR antibody (GFR/1708).")
![Immunohistochemistry-Paraffin: EGFR Antibody (GFR/1708) [NBP2-53198] - Formalin-fixed, paraffin-embedded human Placenta stained with EGFR Antibody (GFR/1708).](http://images.novusbio.com/fullsize/EGFR-Antibody-GFR-1708-Immunohistochemistry-Paraffin-NBP2-53198-img0003.jpg)
![Immunohistochemistry-Paraffin: EGFR Antibody (GFR/1708) [NBP2-53198] - Formalin-fixed, paraffin-embedded human Lung SCC stained with EGFR Monoclonal Antibody (GFR/1708).](http://images.novusbio.com/fullsize/EGFR-Antibody-GFR-1708-Immunohistochemistry-Paraffin-NBP2-53198-img0001.jpg)
![Western Blot: 14-3-3 beta/alpha Antibody (6F6) [NBP3-26247] - Positive Western Blot detected in: U87 whole cell lysate, MCF-7 whole cell lysate, PC3 whole cell lysate, Hela whole cell lysate, SH-SY5Y whole cell lysate, THP-1 whole cell lysate, A549 whole cell lysate, Mouse brain tissue, Rat brain tissue. All lanes: 14-3-3 beta/alpha Antibody at 1: 2000 Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 29, 28 kDa Observed band size: 25-35 kDa](http://images.novusbio.com/fullsize/nbp3-26247_rabbit-14-3-3-beta-alpha-mab-6f6-282202411351616.jpg "Western Blot: 14-3-3 beta/alpha Antibody (6F6) [NBP3-26247] - Positive Western Blot detected in: U87 whole cell lysate, MCF-7 whole cell lysate, PC3 whole cell lysate, Hela whole cell lysate, SH-SY5Y whole cell lysate, THP-1 whole cell lysate, A549 whole cell lysate, Mouse brain tissue, Rat brain tissue. All lanes: 14-3-3 beta/alpha Antibody at 1: 2000 Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 29, 28 kDa Observed band size: 25-35 kDa")
![Immunocytochemistry/Immunofluorescence: 14-3-3 beta/alpha Antibody (6F6) [NBP3-26247] - Staining of PC-3 cell with 14-3-3 beta/alpha Antibody (6F6) at 1:50, counter-stained with DAPI. The cells were fixed in 4% formaldehyde and blocked in 10% normal Goat Serum. The cells were then incubated with the antibody overnight at 4C. The secondary antibody was Alexa Fluor 494-conjugated Goat Anti-Rabbit IgG (H+L).](http://images.novusbio.com/fullsize/nbp3-26247_rabbit-14-3-3-beta-alpha-mab-6f6-282202412493639.jpg)
![Flow Cytometry: 14-3-3 beta/alpha Antibody (6F6) [NBP3-26247] - Overlay Peak curve showing Hela cells stained with 14-3-3 beta/alpha Antibody (6F6) (red line) at 1:100. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26247_rabbit-14-3-3-beta-alpha-mab-6f6-282202414183655.jpg)
![Western Blot: EML4 Antibody [NBP1-05974] - Whole cell lysate from HeLa cells. EML4 was also immunoprecipitated by rabbit anti-EML4 antibody NBP1-05973.](http://images.novusbio.com/fullsize/EML4-Antibody-Western-Blot-NBP1-05974-img0001.jpg "<b>Independent Antibodies Validation. </b>Western Blot: EML4 Antibody [NBP1-05974] - Whole cell lysate from HeLa cells. EML4 was also immunoprecipitated by rabbit anti-EML4 antibody NBP1-05973.")
![<b>Independent Antibodies Validation. </b>Immunohistochemistry-Paraffin: EML4 Antibody [NBP1-05974] - Human ovarian carcinoma. Antibody used at a dilution of 1:1,000.](http://images.novusbio.com/fullsize/EML4-Antibody-Immunohistochemistry-Paraffin-NBP1-05974-img0002.jpg)
![Western Blot: p21/CIP1/CDKN1A Antibody (SR1331) [NBP3-21623] - Western blot analysis using NBP3-21623 in (1) MCF-7 cell lysate; (2) LnCaP cell lysate.](http://images.novusbio.com/fullsize/nbp3-21623_rabbit-p21-cip1-cdkn1a-mab-sr1331-57202316112126.jpg "Western Blot: p21/CIP1/CDKN1A Antibody (SR1331) [NBP3-21623] - Western blot analysis using NBP3-21623 in (1) MCF-7 cell lysate; (2) LnCaP cell lysate.")
![Immunohistochemistry: p21/CIP1/CDKN1A Antibody (SR1331) [NBP3-21623] - Immunohistochemical analysis of paraffin-embedded human colon, using NBP3-21623.](http://images.novusbio.com/fullsize/nbp3-21623_rabbit-p21-cip1-cdkn1a-mab-sr1331-57202317161896.jpg)
![Immunocytochemistry/Immunofluorescence: p21/CIP1/CDKN1A Antibody (SR1331) [NBP3-21623] - Immunofluorescent analysis of MCF7 cells, using NBP3-21623.](http://images.novusbio.com/fullsize/nbp3-21623_rabbit-p21-cip1-cdkn1a-mab-sr1331-6720231051263.jpg)
![Western Blot: TUSC2 Antibody - BSA Free [NBP3-45679] - Human heart tissue were subjected to SDS PAGE followed by western blot with (TUSC2 antibody) at dilution of 1:1000](http://images.novusbio.com/fullsize/nbp3-45679_rabbit-tusc2-pab-bsa-free-284202511352215.jpg "Western Blot: TUSC2 Antibody - BSA Free [NBP3-45679] - Human heart tissue were subjected to SDS PAGE followed by western blot with (TUSC2 antibody) at dilution of 1:1000")
![Immunohistochemistry: TUSC2 Antibody - BSA Free [NBP3-45679] - Immunohistochemistry of paraffin-embedded mouse kidney using (TUSC2 antibody) at dilution of 1:200](http://images.novusbio.com/fullsize/nbp3-45679_rabbit-tusc2-pab-bsa-free-28420251134741.jpg)
![Western Blot: CDK2 [p Tyr 15] Antibody (SR1560) [NBP3-21552] - Western blot analysis using NBP3-21552 in (1) HeLa treated with AP; (2) HeLa cell lysate.](http://images.novusbio.com/fullsize/nbp3-21552_rabbit-cdk2-p-tyr-15-mab-sr1560-57202317215182.jpg "Western Blot: CDK2 [p Tyr 15] Antibody (SR1560) [NBP3-21552] - Western blot analysis using NBP3-21552 in (1) HeLa treated with AP; (2) HeLa cell lysate.")
![Immunohistochemistry: CDK2 [p Tyr 15] Antibody (SR1560) [NBP3-21552] - Immunohistochemical analysis of paraffin-embedded human bladder cancer, using NBP3-21552.](http://images.novusbio.com/fullsize/nbp3-21552_rabbit-cdk2-p-tyr-15-mab-sr1560-5720231564720.jpg)